• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria.原卟啉原和粪卟啉原对人淋巴母细胞及纯化的胆色素原脱氨酶的变构抑制作用。杂色卟啉症急性发作的一种可能机制。
J Clin Invest. 1993 Apr;91(4):1436-44. doi: 10.1172/JCI116348.
2
Protoporphyrinogen oxidase and porphobilinogen deaminase in variegate porphyria.
Eur J Clin Invest. 1986 Jun;16(3):257-61. doi: 10.1111/j.1365-2362.1986.tb01339.x.
3
Rat harderian gland porphobilinogen deaminase: characterization studies and regulatory action of protoporphyrin IX.
Arch Biochem Biophys. 1997 Nov 1;347(1):69-77. doi: 10.1006/abbi.1997.0310.
4
Studies on uroporphyrinogen biosynthesis in pig liver.猪肝中尿卟啉原生物合成的研究。
Z Naturforsch C J Biosci. 1991 Nov-Dec;46(11-12):1101-8. doi: 10.1515/znc-1991-11-1228.
5
ALAD Inhibition by Porphobilinogen Rationalizes the Accumulation of δ-Aminolevulinate in Acute Porphyrias.卟啉原脱氨酶抑制作用可解释急性卟啉病中 δ-氨基酮戊酸的积累。
Biochemistry. 2022 Nov 1;61(21):2409-2416. doi: 10.1021/acs.biochem.2c00434. Epub 2022 Oct 14.
6
Variegate porphyria with coexistent decrease in porphobilinogen deaminase activity.
Acta Derm Venereol. 2001 Oct-Nov;81(5):356-9. doi: 10.1080/000155501317140098.
7
Folding and unfolding of delta-aminolevulinic acid dehydratase and porphobilinogen deaminase induced by uro- and protoporphyrin.尿卟啉和原卟啉诱导的δ-氨基乙酰丙酸脱水酶和胆色素原脱氨酶的折叠与去折叠
Int J Biochem Cell Biol. 1997 Mar;29(3):493-503. doi: 10.1016/s1357-2725(96)00093-3.
8
Alcohol and porphyrin metabolism.酒精与卟啉代谢
Alcohol Alcohol. 2000 Mar-Apr;35(2):109-25. doi: 10.1093/alcalc/35.2.109.
9
The enzymatic defect in variegate prophyria. Studies with human cultured skin fibroblasts.杂色卟啉症的酶缺陷。对人类培养皮肤成纤维细胞的研究。
N Engl J Med. 1980 Apr 3;302(14):765-9. doi: 10.1056/NEJM198004033021401.
10
Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations.急性肝卟啉症:鉴定 46 羟甲基胆素合酶、11 粪卟啉原氧化酶和 20 原卟啉原氧化酶的 46 种新突变。
Mol Genet Metab. 2019 Nov;128(3):352-357. doi: 10.1016/j.ymgme.2018.10.008. Epub 2018 Oct 26.

引用本文的文献

1
mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks.基于信使核糖核酸的疗法在混合型卟啉病兔模型中为急性发作的发病机制提供了新见解。
Mol Ther Nucleic Acids. 2021 May 19;25:207-219. doi: 10.1016/j.omtn.2021.05.010. eCollection 2021 Sep 3.
2
Laboratory Diagnosis of Porphyria.卟啉病的实验室诊断
Diagnostics (Basel). 2021 Jul 26;11(8):1343. doi: 10.3390/diagnostics11081343.
3
Unexpected presentation of acute porphyria.急性卟啉病的意外表现。
BMJ Case Rep. 2021 Jun 29;14(6):e241580. doi: 10.1136/bcr-2021-241580.
4
Acute hepatic porphyria and anaesthesia: a practical approach to the prevention and management of acute neurovisceral attacks.急性肝卟啉病与麻醉:预防和管理急性神经内脏发作的实用方法
BJA Educ. 2021 Feb;21(2):66-74. doi: 10.1016/j.bjae.2020.09.005. Epub 2020 Dec 9.
5
The acute hepatic porphyrias.急性肝卟啉病
Transl Gastroenterol Hepatol. 2021 Apr 5;6:24. doi: 10.21037/tgh-2020-01. eCollection 2021.
6
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria.急性间歇性卟啉症的药物伴侣治疗。
Mol Ther. 2020 Feb 5;28(2):677-689. doi: 10.1016/j.ymthe.2019.11.010. Epub 2019 Dec 4.
7
Acute hepatic porphyrias: Current diagnosis & management.急性肝卟啉症:当前的诊断与管理。
Mol Genet Metab. 2019 Nov;128(3):219-227. doi: 10.1016/j.ymgme.2019.07.002. Epub 2019 Jul 5.
8
[Porphyrias-what is verified?].[卟啉病——已证实的是什么?]
Internist (Berl). 2018 Dec;59(12):1239-1248. doi: 10.1007/s00108-018-0509-z.
9
Partial protoporphyrinogen oxidase (PPOX) gene deletions, due to different Alu-mediated mechanisms, identified by MLPA analysis in patients with variegate porphyria.通过多重连接依赖探针扩增(MLPA)分析鉴定到可变型卟啉症患者的部分原卟啉原氧化酶(PPOX)基因缺失,这些缺失是由不同的 Alu 介导机制引起的。
Orphanet J Rare Dis. 2013 Jan 16;8:13. doi: 10.1186/1750-1172-8-13.
10
Dominant versus recessive: molecular mechanisms in metabolic disease.显性与隐性:代谢性疾病的分子机制
J Inherit Metab Dis. 2008 Oct;31(5):599-618. doi: 10.1007/s10545-008-1016-5. Epub 2008 Oct 21.

本文引用的文献

1
The clinical and biochemical features of variegate porphyria: an analysis of 300 cases studied at Groote Schuur Hospital, Cape Town.杂色卟啉症的临床和生化特征:对开普敦格罗特·舒尔医院研究的300例病例的分析。
Int J Biochem. 1980;12(5-6):837-53. doi: 10.1016/0020-711x(80)90173-1.
2
Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.以胆色素原作为底物,检测红细胞尿卟啉原I合酶活性。
Clin Chem. 1980 Jul;26(8):1182-5.
3
The enzymatic defect in variegate prophyria. Studies with human cultured skin fibroblasts.杂色卟啉症的酶缺陷。对人类培养皮肤成纤维细胞的研究。
N Engl J Med. 1980 Apr 3;302(14):765-9. doi: 10.1056/NEJM198004033021401.
4
Purification and properties of uroporphyrinogen I synthase from human erythrocytes. Identification of stable enzyme-substrate intermediates.人红细胞尿卟啉原I合酶的纯化及性质。稳定酶-底物中间体的鉴定。
J Biol Chem. 1980 Mar 10;255(5):1993-9.
5
A fluorometric assay for measurement of protoporphyrinogen oxidase activity in mammalian tissue.一种用于测量哺乳动物组织中原卟啉原氧化酶活性的荧光测定法。
Clin Chim Acta. 1980 Jan 31;100(3):259-66. doi: 10.1016/0009-8981(80)90275-2.
6
The inherited enzymatic defect in porphyria variegata.迟发性皮肤卟啉症中的遗传性酶缺陷。
Hum Genet. 1981;58(4):425-8. doi: 10.1007/BF00282829.
7
Porphobilinogen deaminase: methods and principles of the enzymatic assay.胆色素原脱氨酶:酶促测定的方法与原理
Enzyme. 1982;28(2-3):146-57. doi: 10.1159/000459098.
8
Porphyria cutanea tarda.迟发性皮肤卟啉病
Semin Liver Dis. 1982 May;2(2):132-42. doi: 10.1055/s-2008-1040703.
9
Protoporphyrinogen oxidase and ferrochelatase in porphyria variegata.杂色卟啉病中的原卟啉原氧化酶和亚铁螯合酶。
Eur J Clin Invest. 1983 Aug;13(4):283-7. doi: 10.1111/j.1365-2362.1983.tb00102.x.
10
Oxygen activation and tetrapyrroles.氧激活与四吡咯
Essays Biochem. 1981;17:1-51.

原卟啉原和粪卟啉原对人淋巴母细胞及纯化的胆色素原脱氨酶的变构抑制作用。杂色卟啉症急性发作的一种可能机制。

Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria.

作者信息

Meissner P, Adams P, Kirsch R

机构信息

MRC/UCT Liver Research Centre, Department of Medicine, Old Groote Schuur Hospital, Observatory, South Africa.

出版信息

J Clin Invest. 1993 Apr;91(4):1436-44. doi: 10.1172/JCI116348.

DOI:10.1172/JCI116348
PMID:7682572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC288118/
Abstract

Variegate porphyria (VP) is characterized by photocutaneous lesions and acute neuropsychiatric attacks. Decreased protoporphyrinogen oxidase activity results in accumulation of protoporphyrin (ogen) IX and coproporphyrin (ogen) III. During acute attacks delta-aminolevulinic acid and porphobilinogen also increase, suggesting that porphobilinogen deaminase (PBG-D) may be rate limiting. We have examined the effects of porphyrinogens accumulating in VP on PBG-D activity in Epstein-Barr virus-transformed lymphoblast sonicates from 12 VP and 12 control subjects. Protoporphyrinogen oxidase activity was decreased and protoporphyrin increased in VP lymphoblasts. PBG-D in control lymphoblasts obeyed Michaelis-Menten kinetics (Vmax 28.7 +/- 1.8 pmol/mg per h, Hill coefficient 0.83 +/- 0.07). VP sonicates yielded sigmoidal substrate-velocity curves that did not obey Michaelis-Menten kinetics. Vmax was decreased (21.2 +/- 2.0 pmol/mg per h) and the Hill coefficient was 1.78 +/- 0.17. Addition of protoporphyrinogen IX and coproporphyrinogen III to control sonicates yielded sigmoidal PBG-D substrate-velocity curves and decreased PBG-D Vmax. Addition of porphyrins or uroporphyrinogen III did not affect PBG-D activity. Removal of endogenous porphyrin (ogens) from VP sonicates restored normal PBG-D kinetics. Purified human erythrocyte PBG-D obeyed Michaelis-Menten kinetics (Vmax 249 +/- 36 nmol/mg per h, Km 8.9 +/- 1.5 microM, Hill coefficient 0.93 +/- 0.14). Addition of protoporphyrinogen yielded a sigmoidal curve with decreased Vmax. The Hill coefficient approached 4. These findings provide a rational explanation for the increased delta-aminolevulinic acid and porphobilinogen during acute attacks of VP.

摘要

混合型卟啉病(VP)的特征是光皮肤损伤和急性神经精神发作。原卟啉原氧化酶活性降低导致原卟啉(原)IX和粪卟啉(原)III积累。在急性发作期间,δ-氨基乙酰丙酸和卟胆原也会增加,这表明卟胆原脱氨酶(PBG-D)可能是限速酶。我们研究了VP中积累的卟啉原对12名VP患者和12名对照者的爱泼斯坦-巴尔病毒转化淋巴细胞超声裂解物中PBG-D活性的影响。VP淋巴细胞中原卟啉原氧化酶活性降低,原卟啉增加。对照淋巴细胞中的PBG-D符合米氏动力学(Vmax为28.7±1.8 pmol/mg每小时,希尔系数为0.83±0.07)。VP超声裂解物产生的S形底物-速度曲线不符合米氏动力学。Vmax降低(21.2±2.0 pmol/mg每小时),希尔系数为1.78±0.17。向对照超声裂解物中添加原卟啉原IX和粪卟啉原III产生S形PBG-D底物-速度曲线,并降低PBG-D Vmax。添加卟啉或尿卟啉原III不影响PBG-D活性。从VP超声裂解物中去除内源性卟啉(原)可恢复正常的PBG-D动力学。纯化的人红细胞PBG-D符合米氏动力学(Vmax为249±36 nmol/mg每小时,Km为8.9±1.5 μM,希尔系数为0.93±0.14)。添加原卟啉原产生Vmax降低的S形曲线。希尔系数接近4。这些发现为VP急性发作期间δ-氨基乙酰丙酸和卟胆原增加提供了合理的解释。